Cabaletta Bio Valuation
| CABA Stock | USD 4.91 0.06 1.24% |
At this time, the firm appears to be undervalued. Cabaletta Bio shows a prevailing Real Value of $9.89 per share. The current price of the firm is $4.91. Our model approximates the value of Cabaletta Bio from analyzing the firm fundamentals such as return on equity of -0.48, and Current Valuation of 43.78 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cabaletta Bio's valuation include:
Price Book 1.2009 | Enterprise Value 43.8 M | Enterprise Value Ebitda (3.44) |
Undervalued
Today
Please note that Cabaletta Bio's price fluctuation is moderately volatile at this time. Calculation of the real value of Cabaletta Bio is based on 3 months time horizon. Increasing Cabaletta Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cabaletta Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cabaletta Stock. However, Cabaletta Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.91 | Real 9.89 | Target 25.29 | Hype 5.24 | Naive 4.82 |
The real value of Cabaletta Stock, also known as its intrinsic value, is the underlying worth of Cabaletta Bio Company, which is reflected in its stock price. It is based on Cabaletta Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cabaletta Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cabaletta Bio helps investors to forecast how Cabaletta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cabaletta Bio more accurately as focusing exclusively on Cabaletta Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cabaletta Bio's intrinsic value based on its ongoing forecasts of Cabaletta Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cabaletta Bio's closest peers. If more than one evaluation category is relevant for Cabaletta Bio we suggest using both methods to arrive at a better estimate.
Cabaletta Bio Cash |
|
Cabaletta Valuation Trend
Comparing Cabaletta Bio's enterprise value against its market capitalization is a good way to estimate the value of Cabaletta Bio uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Cabaletta Bio Total Value Analysis
Cabaletta Bio is currently forecasted to have valuation of 43.78 M with market capitalization of 239.6 M, debt of 5.02 M, and cash on hands of 96.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cabaletta Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
43.78 M | 239.6 M | 5.02 M | 96.81 M |
Cabaletta Bio Asset Utilization
One of the ways to look at asset utilization of Cabaletta is to check how much profit was generated for every dollar of assets it reports. Cabaletta Bio shows a negative utilization of assets of -0.31 percent, losing $0.003113 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cabaletta Bio shows how unproductive it operates for each dollar spent on its assets.Cabaletta Bio Ownership Allocation
The majority of Cabaletta Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cabaletta Bio to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cabaletta Bio. Please pay attention to any change in the institutional holdings of Cabaletta Bio as this could imply that something significant has changed or is about to change at the company.Cabaletta Bio Profitability Analysis
Net Loss for the year was (67.67 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cabaletta Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cabaletta Bio and how it compares across the competition.
About Cabaletta Bio Valuation
The stock valuation mechanism determines Cabaletta Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cabaletta Bio. We calculate exposure to Cabaletta Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cabaletta Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.4 M | -1.5 M |
Cabaletta Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 40.9 M |
Cabaletta Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Cabaletta Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cabaletta we look at many different elements of the entity such as Cabaletta's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cabaletta Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cabaletta Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cabaletta Bio's worth.Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |